Quantuvis Funding: How Much Did They Raise & Key Investors

How Much Did Quantuvis Raise?
Funding & Key Investors

Quantuvis has solidified its position in the healthcare technology sector, securing a total capital infusion of $4.4M to date. The firm recently finalized a major strategic investment of $150K, marking a significant milestone in its operational trajectory. This latest injection of financing underscores the company's resilience and its critical role in modernizing complex financial workflows within the pharmaceutical and payer ecosystem.

By leveraging this capital, Quantuvis continues to demonstrate its capacity to attract substantial backing, reinforcing its status as a pivotal player in the digital transformation of healthcare rebate management. The firm's ability to secure consistent investment across multiple rounds highlights investor confidence in its proprietary SaaS-based architecture.

What is Quantuvis?

Quantuvis

Software

Healthcare Software

Founded in 2013, Quantuvis operates as a specialized Healthcare IT provider, delivering the first integrated SaaS-based solution for rebate management. The company addresses a persistent process gap between pharmaceutical manufacturers and health plans, effectively digitizing and streamlining financial interactions that were historically fragmented. By utilizing deep domain expertise from PBMs and pharma sectors, Quantuvis provides a robust platform that enhances transparency and operational efficiency. The company is currently positioned as a market leader, driving a necessary evolution in how healthcare entities manage complex rebate structures, thereby reducing administrative friction and improving financial accuracy across the industry value chain.

How much funding has Quantuvis raised?

Quantuvis has raised a total of $4.4M across 4 funding rounds:

2014

Private Equity

$1.4M

2015

Private Equity

$1.3M

2017

Private Equity

$1.5M

2020

Debt

$150K

Private Equity (2014): $1.4M, investors not publicly disclosed

Private Equity (2015): $1.3M, investors not publicly disclosed

Private Equity (2017): $1.5M, investors not publicly disclosed

Debt (2020): $150K featuring PPP

Key Investors in Quantuvis

Undisclosed Investors

What's next for Quantuvis?

With the recent infusion of capital, Quantuvis is poised to accelerate its enterprise-level growth strategy. The company is expected to focus on scaling its SaaS infrastructure to accommodate increasing demand from large-scale health plans and pharmaceutical manufacturers. Future initiatives will likely involve expanding the platform's analytical capabilities and deepening its integration with existing healthcare data ecosystems. As the industry moves toward greater transparency, Quantuvis is well-positioned to capitalize on the growing need for automated, data-driven rebate solutions. The firm's strategic roadmap emphasizes long-term value creation, aiming to solidify its market dominance while continuing to innovate within the intersection of healthcare finance and information technology.

See full Quantuvis company page

See More Financial Insights